John Okombo
About
John received his PhD in Chemistry from the University of Cape Town in 2018, where in addition to exploring new chemotypes for antimalarial drug development, his project focused on the reversed chloroquine as a template to designing a novel set of antimalarial compounds that inhibit heme detoxification in Plasmodium. He joined the Fidock lab in the spring of 2018 as a postdoc and has been involved in various projects focusing on understanding the mechanisms antimalarial drug resistance as well as antimalarial target discovery through the Malaria Drug Accelerator program. His work also involves a peptidomics approach to elucidating the potential substrates of the Plasmodium falciparum chloroquine resistance transporter (PfCRT)